G.F. Duncan

Bristol-Myers Squibb (United States)

Papers

1

Total Citations

56

H-Index

1

About

G.F. Duncan is a pharmaceutical chemist recognized for pioneering the use of laboratory robotics in bioanalytical method development. His most cited work, a 1991 study on high-performance liquid chromatography (HPLC) for quantifying nefazodone and its metabolites in human plasma, demonstrates his expertise in automating complex sample preparation and analysis. This method, which has garnered 56 citations, streamlined the detection of antidepressant compounds, improving throughput and reproducibility in pharmacokinetic studies. Duncan’s contributions lie at the intersection of analytical chemistry and automation, enabling faster, more reliable drug monitoring in clinical and research settings. His work has been instrumental in advancing robotic systems for bioanalysis, reducing human error and enhancing efficiency in pharmaceutical laboratories. By integrating robotics with HPLC, Duncan helped set a standard for high-throughput, precise quantification of drugs and their metabolites, impacting both drug development and therapeutic drug monitoring. His research remains a reference point for scientists seeking to automate bioanalytical workflows, underscoring his role in modernizing pharmaceutical analysis.

Research Focus

Key Achievements

1
H-Index
1
Papers
56
Total Citations
56
Avg Citations/Paper
🏆 Most Cited Paper
High-performance liquid chromatographic method for the determination of nefazodone and its metabolites in human plasma using laboratory robotics
56 citations · 1991
📈 Most Prolific Year: 1991 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Bristol-Myers Squibb (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago